Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
These include severe or persistent abdominal pain that may radiate to the back (possible pancreatitis), signs of gallbladder problems such as upper right abdominal pain, fever, or jaundice, sudden changes in vision (possible worsening diabetic retinopathy), severe vomiting or diarrhea leading to dehydration, and any symptoms of a severe allergic reaction
The emphasis on obesity medicine specialization means that providers are typically well-versed in the nuances of GLP-1 therapy, including side effect management, dose improvement, and addressing plateaus
Why Combining GLP-1 & CO2 Fractional Laser is a Game-Changer Pairing Semaglutide weight management treatment with the rejuvenating effects of CO2 Fractional Laser for skin tightening creates a holistic transformation , addressing both internal and external aspects of aging and wellness
Its been a journey